Search Results

Many of the regulatory bodies have issued relief in light of the COVID-19 pandemic. We’ve aggregated a selection of links to help you stay abreast of developments.

A look at venture capital and private equity activity specific to technology companies for 2021, as well as what’s anticipated for 2022.

Completing an initial venture capital (VC) funding round is a huge milestone – this article examines how this can impact any number of processes, including product development and talent procurement, as well as ordinary working capital purposes.

Once an entrepreneur has secured their intellectual property (IP) and received that first round of funding, they have to strategize how to convert it into a fundable business.

Following the securitization of IP, an entrepreneur has to seek funding sources in order to monetize that IP (whether that’s by commercialization or sale).

Intellectual property is a work or invention and the person or people who create it (or their employer) has the rights to it. This article examines the process for securing those rights.

2020 will be remembered as the year the term “work from home” reached a new level. Yet through it all, a vaccine for COVID-19 got started, tested and finalized within a calendar year—demonstrating the appetite for investors believing in science and giving companies the nod to spend their investment dollars on research and development. The beneficiary of all of this was the life science IPO market.

2020 was extremely challenging yet through it all, technology innovation has allowed many to stay connected with one another, continue working and even enable on-line commerce while physical locations were shut down. In fact, technology-focused companies have carved a path forward for business and even thrived.

President-Elect Biden has a history of working with the biopharmaceutical industry, which is expected to continue during his term in office. This article examines just a few points of focus.

Robotics process automation (RPA) continues to play an important role in the digital transformation taking place throughout the business world, particularly in the areas of risk management and business processes.

A discussion of the current state of fintech as it became ever more evident that the financial industry is destined to become an amalgamation of finance and technology.

A discussion of bioinformatics and computational biology, relevant developments, and the outlook for each.

At an IPO roadshow, company leaders are auditing for investor confidence. A successful road show can be the rocket fuel that propels the company into the stratosphere. Here we'll examine a few elements favoring the former.

The 3D printing industry is estimated to grow to approximately $6 billion by 2024. Prosthetics, knee and hip replacements, implants, hearing aids, tissue and medicines are expected to drive 3D-printed biotech products.

Life science companies pursue strategic transactions in several forms, primarily to access various types of capital necessary to effectively compete in the global biopharmaceutical sector. Why are strategic acquisitions popular with life science companies?

Biotech companies are looking for innovative ways to curtail some of the heavy R&D financial burden. The virtual company model presents a potential avenue for biotechs to mitigate some of these enormous costs.

The PATH Act included various changes to the R&D credit related to payroll taxes and the alternative minimum tax (AMT) that are tremendously beneficial for biotech firms - particularly start-ups and small businesses.

Proper management of product launches is essential to minimize negative financial impacts. Successfully developing and implementing a bridging strategy can lead to increased coordination efforts.

For U.S.-based biotech companies, the question is does globalization still make sense? The life science industry is already facing numerous challenges, including varying regulatory and pricing pressures throughout the world.

More than half the medical devices sold in America rely on software, and over 10-million Americans use life-saving medical devices such as pacemakers and infusion pumps. If these devices could be tampered with, it could mean disaster for patients.